Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Neuroimmunol ; 312: 4-7, 2017 11 15.
Artigo em Inglês | MEDLINE | ID: mdl-28886954

RESUMO

There is no consensus approach to safety screening for immune intervention in clinical neuroimmunology. An immunosuppression risk evaluation checklist was used as an audit tool to assess real-world immunosuppression risk management and formulate recommendations for quality improvements in patient safety. Ninety-nine patients from two centres with 27 non-MS diagnoses were included. An average of 1.9 comorbidities with the potential to adversely impact morbidity and mortality associated with immunosuppression were identified. Diabetes and smoking were the most common, however a range of rarer but potentially life-threatening co-morbid disorders in the context of immunosuppression were identified. Inadequate documentation of risk mitigation tasks was common at 40.1% of total tasks across both cohorts. A routine, systematic immunosuppression checklist approach should be considered to improve immunosuppression risk management in clinical neuroimmunology practice.


Assuntos
Lista de Checagem , Auditoria Clínica , Doenças do Sistema Imunitário/epidemiologia , Doenças do Sistema Imunitário/fisiopatologia , Terapia de Imunossupressão , Austrália , Auditoria Clínica/métodos , Auditoria Clínica/normas , Estudos de Coortes , Estudos Transversais , Feminino , Humanos , Doenças do Sistema Imunitário/mortalidade , Masculino , Gestão de Riscos , Reino Unido
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...